Eran Orr: The Need For Better ADHD Screening


Screenings for ADHD have not improved in several years.

While treatment for attention deficit/hyperactivity disorder (ADHD) have improved over time, diagnostics generally have not.

For the last several decades, screenings and diagnostics for ADHD has been done through questionnaires for the patient, as well as for teachers and parents of patients.

There remains a need to improve that.

In an interview with HCPLive®, Evan Orr, Founder and CEO of XRHealth, said he is hopeful that new technology could be used to better screen patients for ADHD.

XRHealth recently unveiled a new ADHD virtual reality platform with the goal of improving well-known ADHD cognitive functioning, including attention, impulsivity, and higher and more complex thinking functions such as initiating, organizing, planning, and fully executing daily tasks.

Orr said the VR tools could be a real boost for ADHD patients, particularly during the coronavirus disease 2019 (COVID-19) pandemic.

The new tool will allow doctors to create virtual worlds where the patient must complete a task while avoiding distractions.

The new system is based on the brain’s ability to restructure itself in attempt to overcome existing challenges, referred to as the brain’s plasticity principle.

Related Videos
Insight on the Promising 52-Week KarXT Data with Rishi Kakar, MD
Sunny Rai, PhD: “I” Language Markers Do Not Detect Depression in Black Individuals
Rebecca A. Andrews, MD: Issues and Steps to Improve MDD Performance Measures
Addressing HS Risks at the Genetic Level, with Kai Li, BSc
A Voice Detecting Depression? Lindsey Venesky, PhD, Discusses New Data
Daniel Karlin, MD: FDA Grants Breakthrough Designation to MM120 for Anxiety
Maternal Hidradenitits Suppurativa Linked to Neonatal Mortality, Pediatric Hospitalization Risk
© 2024 MJH Life Sciences

All rights reserved.